Skip to main content

CGN Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1841506 MANHATTAN, KS

Position in GILD

as of Jun 30, 2026 · filed Jul 6, 2026
Position Value
$3,249,717
-$297,249 QoQ
Shares Held
25,722
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#692
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CGN Advisors LLC holds $16,373,185 across 5 Drug Manufacturers - General names. GILD ranks #4 (19.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 GILD
Gilead Sciences, Inc.
This page
25,722 $3,249,717

All Filings in GILD

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,249,717 25,722
2026-03-31 $3,546,966 25,450
2025-12-31 $3,165,710 25,792
2025-09-30 $2,985,345 26,895
2025-06-30 $2,942,933 26,544
2025-03-31 $2,932,460 26,171
2024-12-31 $2,859,405 30,956
2024-09-30 $2,658,985 31,715
2024-06-30 $1,856,517 27,059
2024-03-31 $210,447 2,873
2023-12-31 $487,275 6,015
2023-09-30 $2,433,826 32,477
2023-06-30 $2,434,255 31,585
2023-03-31 $2,273,212 27,398
2022-12-31 $2,179,216 25,384
2022-09-30 $1,094,010 17,734
2022-06-30 $859,838 13,911
2022-03-31 $562,456 9,461
2021-12-31 $538,185 7,412
2021-09-30 $498,309 7,134
2021-06-30 $452,134 6,566
2021-03-31 $411,563 6,368
2020-12-31 $340,587 5,846